Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, Connecticut United States of America.
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts United States of America.
PLoS Comput Biol. 2022 Aug 30;18(8):e1010465. doi: 10.1371/journal.pcbi.1010465. eCollection 2022 Aug.
Reported COVID-19 cases and deaths provide a delayed and incomplete picture of SARS-CoV-2 infections in the United States (US). Accurate estimates of both the timing and magnitude of infections are needed to characterize viral transmission dynamics and better understand COVID-19 disease burden. We estimated time trends in SARS-CoV-2 transmission and other COVID-19 outcomes for every county in the US, from the first reported COVID-19 case in January 13, 2020 through January 1, 2021. To do so we employed a Bayesian modeling approach that explicitly accounts for reporting delays and variation in case ascertainment, and generates daily estimates of incident SARS-CoV-2 infections on the basis of reported COVID-19 cases and deaths. The model is freely available as the covidestim R package. Nationally, we estimated there had been 49 million symptomatic COVID-19 cases and 404,214 COVID-19 deaths by the end of 2020, and that 28% of the US population had been infected. There was county-level variability in the timing and magnitude of incidence, with local epidemiological trends differing substantially from state or regional averages, leading to large differences in the estimated proportion of the population infected by the end of 2020. Our estimates of true COVID-19 related deaths are consistent with independent estimates of excess mortality, and our estimated trends in cumulative incidence of SARS-CoV-2 infection are consistent with trends in seroprevalence estimates from available antibody testing studies. Reconstructing the underlying incidence of SARS-CoV-2 infections across US counties allows for a more granular understanding of disease trends and the potential impact of epidemiological drivers.
美国(US)报告的 COVID-19 病例和死亡人数提供了 SARS-CoV-2 感染情况的延迟和不完整信息。为了描述病毒传播动态并更好地了解 COVID-19 的疾病负担,需要准确估计感染的时间和规模。我们从 2020 年 1 月 13 日首次报告 COVID-19 病例到 2021 年 1 月 1 日,对美国每个县的 SARS-CoV-2 传播和其他 COVID-19 结果的时间趋势进行了估计。为了做到这一点,我们采用了一种贝叶斯建模方法,该方法明确考虑了报告延迟和病例发现的变化,并根据报告的 COVID-19 病例和死亡人数生成每日 SARS-CoV-2 感染的估计值。该模型作为 covidestim R 包免费提供。在全国范围内,我们估计到 2020 年底已经有 4900 万例有症状的 COVID-19 病例和 404214 例 COVID-19 死亡病例,并且美国 28%的人口已经感染。发病率的时间和规模存在县一级的差异,当地的流行病学趋势与州或地区平均水平有很大不同,这导致到 2020 年底感染人口的估计比例存在很大差异。我们对真正的 COVID-19 相关死亡人数的估计与独立的超额死亡率估计相符,我们对 SARS-CoV-2 感染累积发病率的估计趋势与现有抗体检测研究的血清流行率估计趋势一致。对美国各县 SARS-CoV-2 感染的潜在发病率进行重建,可以更深入地了解疾病趋势和流行病学驱动因素的潜在影响。